Lastest Insider Transactions Of BioXcel Therapeutics, Inc. ( BTAI ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
BTAI | BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | 2023-01-20 | Sell | 50,000 | 30.00 | 1,500,000 | 2023-01-24 20:08:20 |
BTAI | BioXcel Therapeutics, Inc. | O'Neill Vincent | Chief Medical Officer | 2023-01-20 | Sell | 29,713 | 30.00 | 891,390 | 2023-01-24 20:04:38 |
BTAI | BioXcel Therapeutics, Inc. | O'Neill Vincent | Chief Medical Officer | 2023-01-20 | Option Exercise | 29,713 | 0.41 | 12,182 | 2023-01-24 20:04:38 |
BTAI | BioXcel Therapeutics, Inc. | Nandabalan Krishnan | Directior 10% Owner | 2023-01-04 | Sell | 60,000 | 22.01 | 1,320,876 | 2023-01-06 20:00:30 |
BTAI | BioXcel Therapeutics, Inc. | Nandabalan Krishnan | Directior 10% Owner | 2023-01-04 | Option Exercise | 60,000 | 0.41 | 24,600 | 2023-01-06 20:00:30 |
BTAI | BioXcel Therapeutics, Inc. | Mehta Vimal | CEO and President 10% Owner | 2022-12-15 | Sell | 60,000 | 19.69 | 1,181,498 | 2022-12-19 20:00:31 |
BTAI | BioXcel Therapeutics, Inc. | Mehta Vimal | CEO and President 10% Owner | 2022-12-15 | Option Exercise | 60,000 | 0.41 | 24,600 | 2022-12-19 20:00:31 |